Liu, Tingting
Zuo, Hongzhou
Ma, Di
Song, Dan
Zhao, Yuying
Cheng, Oumei
Funding for this research was provided by:
National Natural Science Foundation of China (81871002)
National Natural Science Foundation of China (81471334)
National Natural Science Foundation of China (81100981)
National Key Clinical Specialties Construction Program of China
Article History
Received: 23 April 2023
Accepted: 27 June 2023
First Online: 20 July 2023
Declarations
:
: The studies involving human participants were reviewed and approved by Parkinson’s Progression Markers Initiative. The patients and participants provided their written informed consent to participate in this study.
: Not applicable.
: The authors declare that they have no competing interests.